Lai Mei Pharmaceuticals Co., Ltd.

Regulations of the Board Nomination Committee (May 2026)

Regulations on the Work of the Remuneration and Assessment Committee of the Board of Directors (May 2026)

Regulations on the Work of the Board Strategic Committee (May 2026)

Board Secretary Work System (May 2026)

Independent Director Work System (May 2026)

Internal Audit System (May 2026)

External Investment Management System (May 2026)

Related Party Transaction Management System (May 2026)

Work System for Independent Directors' Special Meetings (May 2026)

Remuneration Management System for Directors and Senior Management (May 2026)

Internal Review System for Information Release and Responses on the Interactive Easy Platform (May 2026)

Fundraising Management System (May 2026)

Investor Relations Management System (May 2026)

Registration System for Insider Information Knowers (May 2026)

General Manager Work Regulations (May 2026)

Emergency Response System for Crisis Management (May 2026)

Management System for Shares Held by Directors and Senior Management (May 2026)

Selection System for Accounting Firms (May 2026)

Audit Committee Work Regulations of the Board of Directors (May 2026)

Management System for Departure of Directors and Senior Executives (May 2026)

Information Disclosure Management System (May 2026)

External Guarantee Management System (May 2026)

Major Information Internal Notification System (May 2026)

System for Accountability of Major Errors in Annual Report Disclosure (May 2026)

Statement and Commitment of Independent Director Candidate (Du Juanjuan)

Independent Director Nominee Statement and Commitment (Du Juanjuan)

Independent Director Nominee Statement and Commitment (Chen Li)

Commitment Letter from Independent Director Candidate Chen Li on Attending Training and Obtaining Qualification Certificate

Commitment Letter from Independent Director Candidate on Attending Training and Obtaining Qualification Certificate (Du Juanjuan)

Statement and Commitment of Independent Director Candidate (Chen Li)

Independent Director Nominee Statement and Commitment (Yan Xinliang)

Nomination Committee's Review of Independent Director Candidates for the Sixth Board

Statement and Commitment of Independent Director Candidate (Yan Xinliang)

Announcement on the Election of the Board of Directors

Announcement on the Election of Employee Representative Directors for the Sixth Board of Directors

Notice of the 2026 First Extraordinary Shareholders' Meeting

Announcement on the 2026 Compensation Plan for Directors and Senior Management

Announcement of Resolutions from the 53rd Meeting of the 5th Board of Directors

Announcement on the Wholly-Owned Subsidiary's Approval Notice for Chemical Raw Material Drug Listing Application

Announcement on the Progress of Participating in the Investment to Establish a Venture Capital Fund

Q1 2026 Report

Legal Opinion from Beijing Zhonglun Law Firm on the 2025 Annual Shareholders' Meeting of Chongqing Laimei Pharmaceutical Co., Ltd.

Announcement of Resolutions from the 2025 Annual Shareholders' Meeting

Announcement on abnormal fluctuations in stock trading

Announcement on Re-appointment of Accounting Firm

Announcement on Conducting Deposit Business with Guangxi Beibu Gulf Bank Co., Ltd. and Related Transactions

Announcement on Applying for Financing Credit Line and Financing Guarantee Plan from Financial Institutions for 2026

Announcement on Providing Financing Credit Guarantee for Chongqing Laimei Longyu Pharmaceutical Co., Ltd.

Notice of Convening the 2025 Annual General Meeting of Shareholders

Announcement of Resolutions of the 51st Meeting of the Fifth Board of Directors

Announcement on the Expiration of the Passive Share Reduction Period for Shareholders Holding 5% or More of Shares

"2025 Annual Performance Report of Independent Director (Huang Tianshun)",

2025 Annual Performance Report of Independent Directors - Chen Xujiang

2025 Annual Performance Report of Independent Directors - Li Changbi

2025 Annual Independent Director's Report - Chen Geng

Announcement on Holding the 2025 Annual Online Performance Briefing Session

2025 Environmental, Social and Governance (ESG) Report

Internal Control Audit Report

2025 Annual Internal Control Evaluation Report

Board of Directors' Explanation on the Rationality of Changes in Accounting Policies

Announcement on Changes in Accounting Policies

Announcement on Accruing Asset Impairment Provisions in 2025

2025 Annual Financial Final Account Report

Resolution Announcement of the 50th Meeting of the Fifth Board of Directors

Special Explanation on the Proposed Non-Distribution of Profits in 2025

Special Verification Report on Deductions from Operating Revenue in 2025

2025 Annual Performance Evaluation Report of Accounting Firm and Audit Committee's Report on Supervising the Accounting Firm's Performance of Duties

Special Audit Report on Non-Operating Fund Occupation and Other Related Fund Transactions in 2025